Skip to main content
Clinical Trials/NCT02778256
NCT02778256
Recruiting
Not Applicable

Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in the Depressive Phase of Bipolar Disorder

Vest Brain,Centro de Estudios Neurovestibulares1 site in 1 country120 target enrollmentJune 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bipolar Disorder
Sponsor
Vest Brain,Centro de Estudios Neurovestibulares
Enrollment
120
Locations
1
Primary Endpoint
Remission rates of depression.
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Vestibular stimulation has been shown to be a very effective noninvasive treatment for major depression. Bipolar disorder is a mental illness that presents cyclic sequences of depressive and euphoric states. Depressive phases of bipolar disorder are difficult to treat and usually are resistant to actual available treatments. This study investigates the effectiveness of a particular technique of vestibular stimulation in a group of 120 bipolar type I and II patients. After randomization 60 of them will receive specific vestibular stimulation (experimental group) and 60 will receive a sham vestibular stimulation.The study will conducted in Vest Brain, Centro de Estudios Neurovestibulares, in Chile.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
October 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Vest Brain,Centro de Estudios Neurovestibulares
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 3 previous weeks with depression symptoms.
  • bipolar disorder type I actual depressive phase
  • bipolar disorder type II actual depressive phase
  • Montgomery Asberg depression scale(MADRS) score equal or more than 20
  • stable psychiatric medication during 2 weeks previous the recruitment

Exclusion Criteria

  • pregnancy
  • neurologic disorder
  • drugs or alcohol abuse during the 2 weeks previous the recruitment
  • presence of maniac state(Young mania scale score more than 7)

Outcomes

Primary Outcomes

Remission rates of depression.

Time Frame: 90 days

Secondary Outcomes

  • Percentage of vestibular change.(90 days)
  • Response rates of depression(90 days)

Study Sites (1)

Loading locations...

Similar Trials